{'fraction_non_alphanumeric': 0.04475982532751092, 'fraction_numerical': 0.019650655021834062, 'mean_word_length': 3.9301075268817205, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[NK cell activity and inhibition by anti-HLA monoclonal antibodies].

The authors followed the effect of anti-HLA class I and II monoclonal antibodies on cytotoxic activity of human NK cells. The mAb 18/5, 23/9 and beta 2m (anti-HLA class I) as well as mAb 20/DR, 30/DR, 13/DP and FB6/DP (anti-HLA class II) were used. Both groups of the antibodies were either tested directly during the cytotoxic test, or NK cells were pre-incubated with them. The application of the antibodies results in an inhibition of NK cell activity by the average of one third. However, the pre-incubation of NK cells with the mAb has not been so unambiguous. On the other hand, the application of anti-HLA class I and class II mAb had no effect on the interaction of NK cells with their target cells. We can conclude that HLA molecules might play a role in the late stages of the cytolytic mechanism of NK cells. (Fig. 1, Tab. 2, Ref. 21.)